🔎 Trials Near Me

Akèy › Kansè san › Wisconsin › Madison

Etid klinik pou Kansè san nan Madison, WI

7 etid pou Kansè san ap chèche patisipan nan sit nan ak bò kote Madison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Ap rekrite
  • UW Carbone Cancer Center, Madison
Laj 18 a 80 · Tout sèks · Mizajou Sep 14, 2026 · NCT07285668

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ap rekriteFaz 3
  • University of Wisconsin, Madison
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • University of Wisconsin - Madison, Madison
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

Ap rekriteFaz 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Laj 2 a 18 · Tout sèks · Mizajou May 5, 2026 · NCT05711667

UWCCC Molecular Tumor Board Registry

Ap rekriteEtid obsèvasyon
  • University of Wisconsin Carbone Cancer Center, Madison
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT03023202

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Ap rekriteFaz 1
  • University of Wisconsin Hospital and Clinics, Madison
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT05735184

Etid Kansè san nan lòt vil

Lòt etid nan Madison

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.